|
1) Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary intima-media thickness by optical coherence tomography; comparison with intravascular ultrasound. Circ J. 2005; 69: 903-7
|
|
|
|
2) Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000; 20: 1262-75
|
|
|
|
|
|
3) Kolodgie FD, Burke AP, Nakazawa G, et al. Is pathologic intimal thickening the key to understanding early plaque progression in human atherosclerotic disease？ Arterioscler Thromb Vasc Biol. 2007; 27: 986-9
|
|
|
|
|
|
4) Doyle B, Caplice N. Plaque neovascularization and antiangiogenic therapy for atherosclerosis. J Am Coll Cardiol. 2007; 49: 2073-80
|
|
|
|
|
|
5) Marc V, Nakano M, Renu V. Small black holes in optical frequency domain imaging matches intravascular neoangiogenesis formation in histology. Eur Heart J. 2010; 31: 1889
|
|
|
|
|
|
6) Kitabata H, Tanaka A, Kubo T, et al. Relation of microchannel structure identified by optical coherence tomography to plaque vulnerability in patients with coronary artery disease. Am J Cardiol. 2010; 105: 1673-8
|
|
|
|
|
|
7) Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003; 108: 1664-72
|
|
|
|
|
|
8) Kume T, Akasaka T, Kawamoto T, et al. Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J. 2006; 152: e751-4
|
|
|
|
|
|
9) Jang IK, Tearney GJ, MacNeill B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation. 2005; 111: 1551-5
|
|
|
|
|
|
10) Yabushita H, Bouma BE, Houser SL, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation. 2002; 106: 1640-5
|
|
|
|
|
|
11) Tearney GJ, Yabushita H, Houser SL, et al. Quantification of macrophage content in athero-sclerotic plaques by optical coherence tomography. Circulation. 2003; 107: 113-9
|
|
|
|
|
|
12) Mac Neill BD, Jang IK, Bouma BE, et al. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol. 2004; 44: 972-9
|
|
|
|
|
|
13) Davies MJ, Thomas A. Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984; 310: 1137-40
|
|
|
|
|
|
14) Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995; 92: 657-71
|
|
|
|
|
|
15) Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intracascular ultrasound and coronary angioscopy. J Am Coll Cardiol. 2007; 50: 933-9
|
|
|
|
|
|
16) Tanaka A, Imanishi T, Kitabata H, et al. Morphology of exersion-triggered plaque rupture in patients with acute coronary syndrome. An optical coherence tomography study. Circulation. 2008; 118: 2368-73
|
|
|
|
|
|
17) Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996; 93: 1354-63
|
|
|
|
|
|
18) Mizukoshi M, Imanishi T, Tanaka A, et al. Clinical classification and plaque morphology determined by optical coherence tomography in unstable angina pectoris. Am J Cardiol. 2010; 106: 323-8
|
|
|
|
|
|
19) Peter L, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med. 2002; 8: 1257-62
|
|
|
|
|
|
20) Takarada S, Imanishi T, Kubo T, et al. Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study. Atherosclerosis. 2009; 202: 491-7
|
|
|
|
|
|
21) Paul M. Ridker, Nader R, Lynda R, et al. Comparison of c-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Eng J Med. 2002; 347: 1557-65
|
|
|
|
|
|
22) Takarada S, Imanishi T, Ishibashi K, et al. The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST elevated acute coronary syndrome: follow-up study by optical coherence tomography and intravascular ultrasound. J Am Coll Cardiol Interv. 2010; 3: 766-72
|
|
|
|
|
|
23) Yamaguchi T, Terashima M, Akasaka T, et al. Safety and feasibility of an intracascular optical coherence tomography image wire system in the clinical setting. Am J Cardiol. 2008; 101: 562-7
|
|
|
|
|
|
24) Takarada S, Imanishi T, Akasaka T, et al. Advantage of next-generation frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion. Catheter Cardiovasc Interv. 2010; 75: 202-6
|
|
|
|
|
|
25) Kubo T, Imanishi T, Takarada S, et al. Comparison of vascular response after sirolimus-eluting stent implantation between unstable angina pectoris and stable angina pectoris: a serial optical coherence tomography study. JACC Cardiovasc Imaging. 2008; 1: 475-84
|
|
|
|
|
|
26) Kubo T, Akasaka T. Reply Letter to: optical coherence tomography to diagnose under-expansion of a drug eluting stent. JACC Cardiovasc Imaging. 2009; 2: 246
|
|
|
|
|
|
27) Tanaka A, Imanishi T, Kitabata H, et al. Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study. Eur Heart J. 2009; 30: 1348-55
|
|
|
|
|
|
28) Kashiwagi M, Kitabata H, Tanaka A, et al. Very late clinical cardiac event after bare-metal stent implantation: a case series in vivo optical coherence tomography examination. J Am Coll Cardiol Img. 2010; 3: 525-7
|
|
|
|
|
|
29) Jingbo H, Hai Q, Maomao Z, et al. Development of lipid-rich plaque inside bare metal stent: possible mechanism of late stent thrombosis？ An optical coherence tomography study. Heart. 2010; 96: 1187-90
|
|
|
|
|
|
30) Kimura T, Abe K, Shizuta S, et al. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation. 2002; 105: 2986-91
|
|
|
|
|
|
31) Inoue K, Abe K, Ando K, et al. Pathological analysis of long-term intracoronary Palmaz-Schatz stenting: is its efficacy permanent？ Cardiovascular Pathlogy. 2004; 13: 109-15
|
|
|
|
|
|
32) Kim J-S, Jang I-K, Kim J-S, et al. Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents. Heart. 2009; 95: 1907-12
|
|
|
|
|
|
33) Miyoshi N, Shite J, Shinke T, et al. Comparison by optical coherence tomography of paclitaxel-eluting stents with sirolimus-eluting stents implanted in one coronary artery in one procedure - 6-month follow-up -. Circ J. 2010; 74: 903-8
|
|
|
|
|
|
34) Nieves G, Patrick WS, Okamura T, et al. Optical coherence tomography pattern of stent restenosis. Am Heart J. 2009; 158: 284-93
|
|
|
|
|
|
35) Nagai H, Ishibashi-Ueda H, Fujii K. Histology of highly echolucent regions in optical coherence tomography images from two patients with silolimus-eluting stent restenosis. Catheter Cardiovasc Interv. 2010; 75: 961-3
|
|
|
|
|
|
36) Guido P, Maehara A, Gabriele G, et al. Optical coherence tomography in unprotected left main coronary artery stenting. EuroIntervention. 2010; 6: 94-9
|
|
|
|
|